GNH USA

Europe — EMA

Okiact (Ketoprofen Lysine)

GNH USA supplies Okiact (Ketoprofen Lysine), a non‑steroidal anti‑inflammatory drug for pain and inflammation. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Ketoprofen Lysine?

Ketoprofen lysine, the active ingredient in Okiact, is a non‑steroidal anti‑inflammatory drug presented as a oral tablet for systemic use. It is indicated for the relief of mild to moderate pain and inflammation in adults.

GNH USA supplies Okiact as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Ketoprofen Lysine used for?

Okiact (ketoprofen lysine) is a NSAID that reduces inflammation and pain in several musculoskeletal conditions. - Rheumatoid arthritis: helps reduce joint swelling, pain and stiffness. - Osteoarthritis: provides symptomatic relief of joint pain and improves mobility. - Acute musculoskeletal injury: alleviates pain and inflammation associated with sprains, strains and bruises. - Post‑operative pain: used as part of multimodal analgesia to control postoperative discomfort. - Dysmenorrhea: reduces menstrual pain and uterine cramping.

What are the side effects of Ketoprofen Lysine?

Ketoprofen lysine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or light‑headedness. - Skin rash or mild itching. - Elevated liver enzymes.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatotoxicity or marked liver injury. - Renal impairment or acute kidney injury. - Anaphylaxis or severe hypersensitivity reactions.

What precautions apply to Ketoprofen Lysine?

When using Okiact, consider the following safety measures: - Assess renal function: patients with impaired kidney function may need dose adjustment. - Monitor hepatic function: avoid use in active liver disease. - Evaluate cardiovascular risk: NSAIDs can increase blood pressure and thrombotic events. - Use gastro‑protective agents: consider co‑prescription in patients with ulcer risk. - Avoid in late pregnancy: NSAIDs are contraindicated in the third trimester. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

What does Ketoprofen Lysine interact with?

Ketoprofen lysine can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - High‑dose aspirin: heightened risk of gastric ulceration.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal protective effects. - Diuretics (especially loop diuretics): potential for reduced kidney function. - Lithium: NSAIDs can increase serum lithium levels. - Methotrexate: reduced clearance may raise toxicity risk.

Frequently asked questions

What is Okiact used for?+
Okiact contains ketoprofen lysine, an NSAID indicated for the relief of mild to moderate pain and inflammation associated with conditions such as rheumatoid arthritis, osteoarthritis, acute musculoskeletal injuries, post‑operative pain and dysmenorrhea. It is prescribed by a healthcare professional based on the individual’s clinical needs.
How does ketoprofen lysine work?+
Ketoprofen lysine inhibits the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain and fever. The lysine salt improves absorption, allowing rapid onset of analgesic and anti‑inflammatory action.
What is the usual dose of Okiact?+
The dosage of Okiact is determined by the prescribing clinician according to the patient’s age, weight, condition being treated and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.
Is Okiact safe during pregnancy or breastfeeding?+
Okiact is generally avoided in the third trimester of pregnancy because NSAIDs can affect fetal cardiovascular development. Use during early pregnancy or while breastfeeding should only be considered if the potential benefit outweighs the risk and under direct medical supervision.
How do I order Okiact from GNH USA?+
To request Okiact, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Okiact compare with other NSAIDs?+
Okiact (ketoprofen lysine) offers a rapid onset of action due to its lysine salt form, which can be advantageous for acute pain. Compared with ibuprofen or naproxen, ketoprofen may provide slightly stronger analgesia at equivalent doses, but it shares similar gastrointestinal and cardiovascular risk profiles typical of NSAIDs.
What are the storage requirements for Okiact?+
Okiact tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and direct sunlight. Do not store in a humid environment such as a bathroom cabinet.
How is Okiact administered?+
Okiact is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with meals may reduce the likelihood of gastrointestinal discomfort.
What are the most serious risks associated with Okiact?+
Serious risks include gastrointestinal bleeding or ulceration, severe skin reactions such as Stevens‑Johnson syndrome, liver injury, kidney impairment and heightened risk of cardiovascular events. Patients should seek immediate medical attention if they notice signs of bleeding, rash, jaundice or sudden swelling.
Who should not use Okiact?+
Okiact should be avoided in individuals with known hypersensitivity to ketoprofen or other NSAIDs, those with active peptic ulcer disease, severe heart failure, significant renal or hepatic impairment, and in the third trimester of pregnancy. A healthcare professional should evaluate suitability before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ketoprofen Lysine
Route
Oral Use
Manufacturer
Dompé Farmaceutici S.P.A.
Origin
EU

Related products